Skip to content
- Home
- Market
- Dr Reddy’s Q4 net profit misses estimates, falls 86% to Rs 221 crore due to cancer therapy losses – Moneycontrol.com
& more related News Here
- Dr Reddy’s Q4 net profit misses estimates, falls 86% to Rs 221 crore due to cancer therapy lossesmoneycontrol.com
- Dr. Reddy’s Q4 results: Company sees huge 86% decline in net profit, revenue falls to ₹7,546 crore YoYupstox
- Dr. Reddy’s Laboratories Q4 results: Cons PAT falls 86% YoY to Rs 221 crore, revenue down 12%; 8 rupees per nightThe Economic Times
- Dr Reddy’s Q4 results: Pharma major declares 800% dividend to Rs 220 crore despite 86% decline in profitzee business
- Dr. Reddy’s Q4 preview: Revenue decline, net profit likelybusiness Line
